FDA approves new treatment to slow progression of early Alzheimer's

The FDA approved a new Alzheimer's treatment called donanemab on Tuesday. It is designed to help patients in the early stages of the disease. CBS News chief medical correspondent Dr. Jon LaPook explains what to know.

Jul 3, 2024 - 17:30
 0  2
FDA approves new treatment to slow progression of early Alzheimer's
The FDA approved a new Alzheimer's treatment called donanemab on Tuesday. It is designed to help patients in the early stages of the disease. CBS News chief medical correspondent Dr. Jon LaPook explains what to know.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow